Dr. Lin is an associate professor in the Section of Oral Medicine, Oral Pathology, and Orofacial Pain in the Division of Diagnostic and Surgical Sciences at the UCLA School of Dentistry.

Additional Information

Didactic Courses Taught:

  • PPID Oral Pathology, AS114, Course Chair
  • Oral Pathology / Medicine for Dental Residents, DS300.40, Course Chair
  • Foundations of Basic Science: Introduction to Histology and Pathology, OSD111
  • System 4: Neuroanatomy & musculoskeletal systems, OSD 210
  • Oral Diseases 2, OSD 202
  • Oral Diseases 3, OSD 203

Patient Care Activities:

Dr. Lin reviews cases submitted to the UCLA Oral Pathology Diagnostic Laboratory 

Research & Interests

Dr. Yi-Ling Lin's research focuses on transcription regulation during osteoclast differentiation. The lab is aiming at developing therapeutic strategies to inhibit osteoclast activity for osteolytic diseases such as periodontitis and cancer bone metastasis.
 

Fax: (310) 825-7232

  • D.D.S., National Yang-Ming University, Taiwan, 1989
  • D.M.Sc. in Oral Biology, Certificate in Oral Pathology, Harvard School of Dental Medicine, 1997
  • Certificate in Clinical Research, Harvard School of Dental Medicine, 1999
  • Postdoc., Dana Farber Cancer Institute, 2003
  • Yoon JH, Li M, Basile JR, Lin YL. Computer-assisted analysis of immunohistological parameters in oral giant cell granulomas. Oral Dis. 2019;25(3):796-802. doi: 10.1111/odi.13022. PubMed PMID: 30565380.
  • Li M, McGhee EM, Shinno L, Lee K, Lin YL. Exposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human  Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo. Am J Pathol. 2021. Epub 2021/07/03. doi: 10.1016/j.ajpath.2021.06.005. PubMed PMID: 34214507.
  • Li M, Basile JR, Mallya S, Lin YL. The impact and outcomes of cancer-macrophage fusion. BMC Cancer. 2023;23(1):497. Epub 20230601. doi: 10.1186/s12885-023-10961-9. PubMed PMID: 37264310; PMCID: PMC10236829.

Read all the publications: